CAS 268546-19-6

6H-1,3,6,8a-Tetraazaacenaphthylene,6-(cyclopropylmethyl)-2-(2,4-dichlorophenyl)-7-ethyl-7,8-dihydro-4-methyl-, (7S)-

Description:

6H-1,3,6,8a-Tetraazaacenaphthylene, 6-(cyclopropylmethyl)-2-(2,4-dichlorophenyl)-7-ethyl-7,8-dihydro-4-methyl-, (7S)-, identified by CAS number 268546-19-6, is a complex organic compound characterized by its multi-ring structure and the presence of multiple nitrogen atoms within its framework, which contributes to its unique chemical properties. This compound features a tetraazaacenaphthylene core, indicating a fused ring system that incorporates nitrogen atoms, enhancing its potential for coordination with metal ions and influencing its electronic properties. The presence of substituents such as cyclopropylmethyl and 2,4-dichlorophenyl groups introduces additional steric and electronic effects, which can affect its reactivity and solubility. The compound's stereochemistry, denoted by the (7S) configuration, suggests specific spatial arrangements that may play a crucial role in its biological activity or interaction with other molecules. Overall, this substance may exhibit interesting pharmacological properties, making it a candidate for further research in medicinal chemistry and materials science.

Formula: C₂₁H₂₂Cl₂N₄

NBI-35965

CAS: 268546-19-6

NBI-35965 is a CRF1 receptor antagonist.

Formula: C₂₁H₂₂Cl₂N₄

Color and Shape: Solid

Molecular weight: 401.33

Ref: TM-T69544